Untitled Document
OHSU Where Healing, Teaching and Discovery Come Together
OHSU Search OHSU OHSU Site Map Contact
OHSU Division of Hematology and Medical Oncology
About the Division Care Centers Patient Resources Our Faculty Research and Education News and Events
Dedicated to the study and treatment of cancer and disorders of the blood.

 
undefined

Our Faculty

Charles D. Blanke, M.D.
Professor of Medicine

Specialty: GI Oncology

Clinic Phone: 503-494-6594
Office Phone: 503-494-1556
E-mail: blankec@ohsu.edu

 

My major research interest involves investigation into the best therapy for gastrointestinal stromal and colorectal tumors. We also see patients with nearly all forms of gastrointestinal malignancies.

 
Appointments

  • Professor, Department of Medicine

 

Professional Education and Training

  • 1981-1983: Northwestern University, BS in Medicine
  • 1983-1988: Northwestern University, MD w/Distinction
  • 1988-1991: Gunderson Medical Foundation, Internal Medicine Internship/Residency
  • 1991-1994: Indiana University, Hematology/Oncology Fellowship
  • 1999: ASCO/AACR Methods in Clinical Cancer Research Workshop
  • 2000: NIH Protection of Human Research Subjects Course
  • 2003: HIPAA Education Course, VHA Privacy Policy Training, VA Good Clinical Practice Web Training, NIH Human Participants Protection Education for Research Teams, VA Human Research Protection Program Training Module
  • 2004: OHSU Respect at the University
Personal


Other


 
Selected Publications

  • Blanke C, Ansari R, Mantravadi R, Gonin R, Tokars R, Fisher W, Pennington K, O'Connor T, Rynard S, Miller M, Einhorn L: A phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small cell lung cancer: A Hoosier Oncology Group protocol. J Clin Oncol 13:1425-1429, 1995.
  • Blanke C, Loehrer P, Nichols C, Einhorn L: A phase II trial of VP-16, ifosfamide, cisplatin, vinblastine, and bleomycin in advanced germ cell tumors. Am J Clin Oncol 19:487-491, 1996.
  • Blanke C, Delgalvis S, Nichols C: Late recurrence of seminoma. South Med J 90:653-655, 1997.
  • Blanke C, DeVore R, Shyr Y, Murray M, Epstein B, Hande K, Stewart S, Johnson D: A pilot study of protracted low-dose cisplatin and etoposide with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer. Int J Radiot Biol Phys 37:111-116, 1997.
  • Blanke C, Kasimis B, Schein P, Capizzi R, Kurman M: A phase II study of trimetrexate, 5-fluorouracil, and leucovorin for advanced colorectal cancer. J Clin Oncol 15:915-920, 1997.
  • Blanke C, Stipanov M, Morrow J, Rothenberg M, Chinery R, Shyr Y, Coffey R, Johnson D, Leach S, Beauchamp R: A Phase I study of vitamin E, 5-fluorouracil, and leucovorin for advanced malignancies. Invest New Drugs 19:21-27, 2001.
  • Saltz L, Cox J, Blanke C, Rosen L, Fehrenbacher L, Moore M, Maroun J, Ackland S, Locker P, Pirotta N, Elfring G, Miller L: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 343:905-914, 2000.

Search PubMed for more publications